๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Quantification of matrix metalloproteinase activity in plasma of patients enrolled in a BAY 12-9566 phase I study

โœ Scribed by Wilhelmina C.M. Duivenvoorden; Holger W. Hirte; Gurmit Singh

Publisher
John Wiley and Sons
Year
2001
Tongue
French
Weight
103 KB
Volume
91
Category
Article
ISSN
0020-7136

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

KP1019, A New Redox-Active Anticancer Ag
KP1019, A New Redox-Active Anticancer Agent โ€“ Preclinical Development and Results of a Clinical Phase I Study in Tumor Patients
โœ Christianโ€…G. Hartinger; Michaelโ€…A. Jakupec; Stefanie Zorbas-Seifried; Michael Gr ๐Ÿ“‚ Article ๐Ÿ“… 2008 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 347 KB ๐Ÿ‘ 1 views

## Abstract The promising drug candidate indazolium __trans__โ€[tetrachlorobis(1__H__โ€indazole)ruthenate(III)] (KP1019) is the second Ruโ€based anticancer agent to enter clinical trials. In this review, which is an update of a paper from 2006 (__Hartinger etโ€…al., J. Inorg. Biochem.__ **2006**, __100_

ChemInform Abstract: KP1019, A New Redox
ChemInform Abstract: KP1019, A New Redox-Active Anticancer Agent โ€” Preclinical Development and Results of a Clinical Phase I Study in Tumor Patients
โœ Christian G. Hartinger; Michael A. Jakupec; Stefanie Zorbas-Seifried; Michael Gr ๐Ÿ“‚ Article ๐Ÿ“… 2009 ๐Ÿ› John Wiley and Sons โš– 16 KB

## Abstract ChemInform is a weekly Abstracting Service, delivering concise information at a glance that was extracted from about 200 leading journals. To access a ChemInform Abstract of an article which was published elsewhere, please select a โ€œFull Textโ€ option. The original article is trackable v